利润表（梅花生物）
| 上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
| 报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
| 一、营业总收入(元) | 18,680,785,476.06 | 12,642,718,053.37 | 6,486,560,309.24 | 27,760,612,259.07 | 20,526,171,453.75 | 13,588,270,517.23 | 6,950,072,385.57 |
| 营业收入(元) | 18,680,785,476.06 | 12,642,718,053.37 | 6,486,560,309.24 | 27,760,612,259.07 | 20,526,171,453.75 | 13,588,270,517.23 | 6,950,072,385.57 |
| 二、营业总成本(元) | 16,648,960,494.80 | 11,156,817,653.82 | 5,754,966,816.91 | 24,158,622,972.00 | 18,070,945,779.49 | 11,941,801,915.19 | 6,032,828,884.18 |
| 营业成本(元) | 15,149,363,557.23 | 10,177,206,263.13 | 5,232,609,548.22 | 22,297,122,025.25 | 16,739,334,868.73 | 11,083,605,972.67 | 5,570,850,209.41 |
| 研发费用(元) | 285,461,019.60 | 180,479,234.74 | 90,844,311.14 | 314,222,682.89 | 234,168,723.06 | 149,290,010.79 | 70,825,927.68 |
| 营业税金及附加(元) | 175,637,343.60 | 115,408,867.54 | 54,100,872.32 | 242,593,736.35 | 182,715,154.03 | 118,201,953.51 | 57,677,377.70 |
| 销售费用(元) | 290,839,474.29 | 204,453,466.84 | 109,209,195.68 | 413,512,921.96 | 306,810,022.38 | 222,525,723.79 | 124,529,653.80 |
| 管理费用(元) | 819,350,604.16 | 554,506,366.51 | 302,966,862.94 | 924,598,280.87 | 629,017,955.75 | 376,668,549.78 | 190,344,198.17 |
| 财务费用(元) | -71,691,504.08 | -75,236,544.94 | -34,763,973.39 | -33,426,675.32 | -21,100,944.46 | -8,490,295.35 | 18,601,517.42 |
| 其中：利息费用(元) | 65,518,228.32 | 46,859,883.13 | 23,644,161.14 | 115,220,289.90 | 85,716,419.95 | 59,495,510.64 | 31,707,377.37 |
| 其中：利息收入(元) | 83,996,787.45 | 59,735,278.47 | 34,617,303.50 | 118,865,910.23 | 79,356,020.17 | 47,111,306.88 | 23,977,591.51 |
| 三、其他经营收益 | |||||||
| 加：公允价值变动收益(元) | 8,763,064.93 | 1,959,926.94 | 260,000.32 | -38,116,002.85 | -40,168,704.78 | -29,113,667.60 | -2,097,596.34 |
| 加：投资收益(元) | 20,742,760.03 | 14,671,408.04 | 3,912,130.43 | 7,627,189.35 | -1,153,057.29 | 2,532,420.46 | 1,742,134.69 |
| 其中：对联营企业和合营企业的投资收益(元) | -4,155,246.61 | -2,220,562.67 | -593,307.53 | 1,845,935.98 | 1,074,341.17 | 1,465,939.60 | 294,000.00 |
| 资产处置收益(元) | -2,427,954.12 | 1,598,224.17 | 468,261.36 | 4,073,026.92 | 2,481,311.21 | 2,456,981.19 | - |
| 资产减值损失(元) | -1,857,388.63 | -1,987,907.91 | - | -5,415,349.06 | -918,528.02 | -1,409,550.67 | 33,292.65 |
| 信用减值损失(元) | 6,173,620.92 | 6,162,617.22 | - | -5,225,785.54 | -6,877,434.93 | -7,415,485.96 | 1,223,812.27 |
| 其他收益(元) | 210,447,791.63 | 174,432,864.62 | 149,619,138.69 | 248,461,028.47 | 176,521,208.23 | 43,546,575.54 | 26,985,866.20 |
| 四、营业利润(元) | 2,273,666,876.02 | 1,682,737,532.63 | 885,853,023.13 | 3,813,393,394.36 | 2,585,110,468.68 | 1,657,065,875.00 | 945,131,010.86 |
| 加：营业外收入(元) | 105,472,109.03 | 66,373,971.73 | 839,433.54 | 10,357,039.99 | 6,238,092.40 | 3,878,667.01 | 1,001,714.04 |
| 减：营业外支出(元) | 37,189,601.53 | 31,820,702.21 | 11,161,236.80 | 100,614,814.20 | 56,731,357.04 | 47,456,761.33 | 8,294,888.14 |
| 五、利润总额(元) | 2,341,949,383.52 | 1,717,290,802.15 | 875,531,219.87 | 3,723,135,620.15 | 2,534,617,204.04 | 1,613,487,780.68 | 937,837,836.76 |
| 减：所得税费用(元) | 346,627,735.23 | 243,467,012.23 | 123,826,654.08 | 542,185,924.67 | 374,103,252.97 | 242,643,815.80 | 137,044,709.29 |
| 六、净利润(元) | 1,995,321,648.29 | 1,473,823,789.92 | 751,704,565.79 | 3,180,949,695.48 | 2,160,513,951.07 | 1,370,843,964.88 | 800,793,127.47 |
| (一)按经营持续性分类 | |||||||
| 持续经营净利润(元) | 1,995,321,648.29 | 1,473,823,789.92 | 751,704,565.79 | 3,180,949,695.48 | 2,160,513,951.07 | 1,370,843,964.88 | 800,793,127.47 |
| (二)按所有权归属分类 | |||||||
| 归属于母公司股东的净利润(元) | 1,995,321,648.29 | 1,473,823,789.92 | 751,704,565.79 | 3,180,949,695.48 | 2,160,513,951.07 | 1,370,843,964.88 | 800,793,127.47 |
| 扣除非经常性损益后的净利润(元) | 1,769,096,254.31 | 1,302,850,887.62 | 636,707,025.33 | 3,083,801,516.17 | 2,098,472,845.07 | 1,406,493,134.64 | 786,151,871.17 |
| 七、每股收益 | |||||||
| 一、基本每股收益(元) | 0.68 | 0.50 | 0.26 | 1.06 | 0.72 | 0.45 | 0.26 |
| 二、稀释每股收益(元) | 0.68 | 0.50 | 0.26 | 1.06 | 0.72 | 0.45 | 0.26 |
| 八、其他综合收益(元) | 39,914,573.30 | -30,039,576.10 | 10,898,041.98 | -535,384,994.54 | 287,459,668.83 | 919,739,712.58 | - |
| 归属于母公司股东的其他综合收益(元) | 39,914,573.30 | -30,039,576.10 | 10,898,041.98 | -535,384,994.54 | 287,459,668.83 | 919,739,712.58 | - |
| 九、综合收益总额(元) | 2,035,236,221.59 | 1,443,784,213.82 | 762,602,607.77 | 2,645,564,700.94 | 2,447,973,619.90 | 2,290,583,677.46 | 800,793,127.47 |
| 归属于母公司所有者的综合收益总额(元) | 2,035,236,221.59 | 1,443,784,213.82 | 762,602,607.77 | 2,645,564,700.94 | 2,447,973,619.90 | 2,290,583,677.46 | 800,793,127.47 |
| 公告日期 | 2024-10-23 | 2024-07-30 | 2024-04-09 | 2024-03-19 | 2023-10-19 | 2023-08-19 | 2023-04-29 |
| 审计意见(境内) | 标准无保留意见 | ||||||
| 原始财报文件下载 | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) |
| 上市前/上市后 |
| 报表类型 |
| 一、营业总收入(元) |
| 营业收入(元) |
| 二、营业总成本(元) |
| 营业成本(元) |
| 研发费用(元) |
| 营业税金及附加(元) |
| 销售费用(元) |
| 管理费用(元) |
| 财务费用(元) |
| 其中：利息费用(元) |
| 其中：利息收入(元) |
| 三、其他经营收益 |
| 加：公允价值变动收益(元) |
| 加：投资收益(元) |
| 其中：对联营企业和合营企业的投资收益(元) |
| 资产处置收益(元) |
| 资产减值损失(元) |
| 信用减值损失(元) |
| 其他收益(元) |
| 四、营业利润(元) |
| 加：营业外收入(元) |
| 减：营业外支出(元) |
| 五、利润总额(元) |
| 减：所得税费用(元) |
| 六、净利润(元) |
| (一)按经营持续性分类 |
| 持续经营净利润(元) |
| (二)按所有权归属分类 |
| 归属于母公司股东的净利润(元) |
| 扣除非经常性损益后的净利润(元) |
| 七、每股收益 |
| 一、基本每股收益(元) |
| 二、稀释每股收益(元) |
| 八、其他综合收益(元) |
| 归属于母公司股东的其他综合收益(元) |
| 九、综合收益总额(元) |
| 归属于母公司所有者的综合收益总额(元) |
| 公告日期 |
| 审计意见(境内) |
| 原始财报文件下载 |
Showing 1 to 42 of 42 entries